• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
SLE: Therapy
Avoid sunlight exposure
NSAIDs for arthritis if no renal toxicity
Hydroxychloroquine for skin and joints
Steroids for acute flares and organ involvement
Cyclophosphamide for life–threatening manifestations
Other immunosuppressants
Azathioprine
Mycophenolate
Symmetric inflammatory arthritis with systemic vasculitis
Rheumatoid Arthritis/Disease. Onset as young–middle aged adults (45–65 years old)
Rheumatoid Arthritis/Disease HLA associations
HLA–B27 seen in 70% of Caucasians
HLA DR4, RR = 49
Rheumatoid Arthritis/Disease pathogenesis
Overactivity of Th2 cells –> RheumatoidFactor –> immune complexes in joint–> pannus formation of synovial lining –> joint destruction
Rheumatoid Disease presentation in joints
synovitis with erosion of articular cartilage/marginal bone
MCP, PIP (never DIP like OA) C1 and C2
Rheumatoid disease presentation in the
1-skin
2-cardiovascular
3-lung
4-eye
5-neurologic
6-renal
Skin: rheumatoid nodules, ulcers
Cardiovascular: vasculitis, pericarditis, MI, CHF, higher mortality
Lung: nodules, pleuritis, interstitial fibrosis
Eye: scleritis, conjunctivitis
Neurologic: mononeuritis, compression neuropathy
Renal: amyloidosis
Rheumatoid disease lab findings
Anti–cyclic citrullinated peptide antibodies more specific

Rheumatoid factor
Elevated erythrocyte sedimentation rate

Hypochromic/normochromic normocytic anemia
Granulocytopenia (Felty’s syndrome)
An anti–IgG Fc fragment Ab (usually IgM class) aka rheumatoid factor titer correlates with
Degree of joint erosion
Systemic vasculitis
Overall prognosis
-Increases with age in healthy adults
Anti–Citrullinated Cyclic Peptide Antibodies (ACPA) development
Peptidyl arginine deiminase performs post-translational modification of arginine to citrulline in cyclic peptides
This is upregulated in inflammatory states
This alters the cyclic peptide’s conformation and may make it antigenic in susceptible individuals
Anti–Citrullinated Cyclic Peptide Antibodies (ACPA)
Peptidyl arginine deiminase performs post-translational modification of arginine to citrulline in cyclic peptides
This is upregulated in inflammatory states
This alters the cyclic peptide’s conformation and may make it antigenic in susceptible individuals
what is the significance of ACPA in rheumatoid arthritis
Present in 50% at presentation, 80% eventually (~RF)
Specificity > 90%
ACR Criteria for Rheumatoid Disease Need ≥ 4
Morning stiffness for > 1 hour*
Soft tissue swelling of a least 3 joints*
PIP, MCP or wrist swelling (never DIP)*
Symmetric joint swelling*
Rheumatoid nodules
Rheumatoid factor (seen in 80%)
X–ray erosions, osteopenia in hands or wrist
*must be present for 6 weeks
Rheumatoid Disease: Therapy
Disease Modifying Antirheumatic Drugs (DMARDs)-This need to give early!
Glucocorticoids

NSAIDs
Anticytokine Therapy
Unique Side–Effects of Anticytokine Therapy
Infections ex
-Tuberculosis
-Opportunistic infections
Malignancies
Demyelination
Autoimmune phenomena